Cochrane Abstracts
Rivastigmine for vascular cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rivastigmine for Vascular Cognitive Impairment." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433506/all/Rivastigmine_for_vascular_cognitive_impairment.
Rivastigmine for vascular cognitive impairment. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433506/all/Rivastigmine_for_vascular_cognitive_impairment. Accessed November 22, 2024.
Rivastigmine for vascular cognitive impairment. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433506/all/Rivastigmine_for_vascular_cognitive_impairment
Rivastigmine for Vascular Cognitive Impairment [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433506/all/Rivastigmine_for_vascular_cognitive_impairment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rivastigmine for vascular cognitive impairment
ID - 433506
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433506/all/Rivastigmine_for_vascular_cognitive_impairment
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
